Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | acetyl-coA carboxylase ACC2 | 0.0287 | 1 | 1 |
Brugia malayi | Carboxyl transferase domain containing protein | 0.0277 | 0.9595 | 1 |
Toxoplasma gondii | acetyl-CoA carboxylase ACC1 | 0.0287 | 1 | 1 |
Schistosoma mansoni | acetyl-CoA carboxylase | 0.0287 | 1 | 1 |
Mycobacterium ulcerans | bifunctional protein acetyl-/propionyl-coenzyme a carboxylase (alpha chain) AccA3 | 0.0109 | 0.2839 | 1 |
Trypanosoma brucei | acetyl-CoA carboxylase | 0.0287 | 1 | 1 |
Mycobacterium tuberculosis | Probable pyruvate carboxylase Pca (pyruvic carboxylase) | 0.0109 | 0.2839 | 1 |
Leishmania major | carboxylase, putative | 0.0109 | 0.2839 | 0.2839 |
Chlamydia trachomatis | biotin carboxylase | 0.0099 | 0.2433 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.1157 | 0.1157 |
Trypanosoma cruzi | acetyl-CoA carboxylase | 0.0177 | 0.5594 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0067 | 0.1157 | 0.0644 |
Trypanosoma brucei | unspecified product | 0.0072 | 0.1329 | 0.1329 |
Trypanosoma brucei | RNA helicase, putative | 0.0099 | 0.241 | 0.241 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.0109 | 0.2839 | 0.2839 |
Schistosoma mansoni | pyruvate carboxylase | 0.0109 | 0.2839 | 0.2839 |
Plasmodium vivax | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.0207 | 0.6803 | 0.5 |
Echinococcus multilocularis | propionyl coenzyme A carboxylase alpha chain | 0.0109 | 0.2839 | 0.2839 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.1157 | 0.1157 |
Echinococcus granulosus | propionyl coenzyme A carboxylase alpha chain | 0.0109 | 0.2839 | 0.2839 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.1157 | 0.1157 |
Loa Loa (eye worm) | TAR-binding protein | 0.0067 | 0.1157 | 0.0644 |
Brugia malayi | RNA binding protein | 0.0067 | 0.1157 | 0.0644 |
Plasmodium falciparum | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.0207 | 0.6803 | 0.5 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.0109 | 0.2839 | 0.5074 |
Leishmania major | acetyl-CoA carboxylase, putative | 0.0287 | 1 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0067 | 0.1157 | 0.1157 |
Mycobacterium ulcerans | pyruvate carboxylase | 0.0109 | 0.2839 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0067 | 0.1157 | 0.1157 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.0109 | 0.2839 | 0.2839 |
Wolbachia endosymbiont of Brugia malayi | Acetyl/propionyl-CoA carboxylase, alpha subunit | 0.0109 | 0.2839 | 1 |
Mycobacterium tuberculosis | Probable acetyl-/propionyl-coenzyme A carboxylase alpha chain (alpha subunit) AccA2: biotin carboxylase + biotin carboxyl carrie | 0.0109 | 0.2839 | 1 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.0109 | 0.2839 | 0.2839 |
Giardia lamblia | Acetyl-CoA carboxylase/pyruvate carboxylase fusion protein, putative | 0.0049 | 0.0405 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.1157 | 0.1157 |
Entamoeba histolytica | acetyl-coA carboxylase, putative | 0.0049 | 0.0405 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0127 | 0.3568 | 0.3317 |
Loa Loa (eye worm) | RNA binding protein | 0.0067 | 0.1157 | 0.0644 |
Mycobacterium ulcerans | acetyl-/propionyl-coenzyme a carboxylase alpha chain AccA1 | 0.0109 | 0.2839 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0127 | 0.3568 | 0.3317 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.1157 | 0.1157 |
Loa Loa (eye worm) | carboxyl transferase domain-containing protein | 0.0277 | 0.9595 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0099 | 0.241 | 0.241 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0067 | 0.1157 | 0.0644 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.0109 | 0.2839 | 0.2839 |
Mycobacterium leprae | Probable bifunctional protein acetyl-/propionyl-coenzyme A carboxylase, alpha chain AccA3 (BccP) | 0.0109 | 0.2839 | 1 |
Echinococcus multilocularis | acetyl coenzyme A carboxylase 1 | 0.0287 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0067 | 0.1157 | 0.0644 |
Toxoplasma gondii | pyruvate carboxylase | 0.0109 | 0.2839 | 0.2839 |
Mycobacterium ulcerans | acetyl-/propionyl-coenzyme a carboxylase alpha chain, AccA2 | 0.0109 | 0.2839 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0127 | 0.3568 | 0.3317 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.0109 | 0.2839 | 0.5074 |
Leishmania major | methylcrotonoyl-coa carboxylase biotinylated subunitprotein-like protein | 0.0109 | 0.2839 | 0.2839 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (binding) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.